PL EN


Preferences help
enabled [disable] Abstract
Number of results
2021 | 34 | 38-53
Article title

A review on cancer treatment and the risk developing severe mental illness

Content
Title variants
Languages of publication
EN
Abstracts
EN
Cancer, the second primary cause of death for patients with serious mental illness (SMI) continues to be responsible for over 14 million new cases and approximately 8 million cases annually. Delays in diagnosis and unequal access to cancer care contribute to cancer mortality that is two to fourfold higher in people with SMI than in the general populace. Severe mental illness is an emotional, mental and behavioural disorder leading to a serious impairment and ultimately has major effect of life activities. Patients with the history of severe mental illness are at high risk of incurable cancer via a number of factors including overshadowing of diagnosis, low socioeconomic level and fragmented healthcare. Likewise, individual diagnosed and undergoing cancer therapy are prone to develop mental illness as an aftermath of chemotherapy. Averagely, patients with serious mental illness, for example bipolar disorder and schizophrenia, die 15-20 years earlier than the general populace, and thus widening the mortality gap. The primary causes of death for this population include cancer and cardiovascular disease, signifying that access to appropriate and timely precautionary services could help decrease untimely deaths. Also, severe mental illness can be effectively managed with increased access to mental-based treatment services to reduced related morbidity. Therefore, having a better understanding of subjects regarding early detection of cancer, mental health treatment/management and the association between these, could have a significant step in detecting possible causes of early mortality in patients with SMI.
Discipline
Year
Volume
34
Pages
38-53
Physical description
Contributors
  • Department of Biochemistry, College of Medicine, University of Ibadan, Ibadan, Oyo state Nigeria
References
  • [1] Abdullah KN, Janardhan R, Hwang M, Williams CD, Farasatpour M, Margenthaler JA, et al. Adjuvant radiation therapy for breast cancer in patients with schizophrenia. Am J Surg. (2015); 209(2):378–84. Epub 2014/12/03. https://doi.org/10.1016/j.amjsurg.2014.07.004 PMID: 25450588.
  • [2] Adams C, Grey N, Magrath I, Miller A, Torode J. The World Cancer Declaration: is the world catching up? Lancet Oncol (2010) 11: 1018–20
  • [3] Adesina MA, Kanmodi KK, Fagbule OF, Ogunmuko T. Unfavorable family background is associated with smoking at youthful age. International Journal of Child Health and Human Development (2019) 12(2): 139-144
  • [4] Adesina MA, Oladele RI, Olufadewa II, Iyiola O, Ekott M, Oladipupo D, Nwachukwu P, Baru A, Akinloye Seyi. Addressing High Burden of Non-Communicable Diseases in Nigeria. Journal of Health Research (2021) 35(4)
  • [5] Adesina MA, Oladele RI, Olufadewa II. Mental health and psychosocial support in conflicting Nigeria. Yenegoa Medical Journal (2020) 2(4): 15-23
  • [6] Adesina MA. Prevalence of psychoactive substances in Nigeria and United States of America. Conference Programme and Book of Abstract of Federation of African Medical Students General Assembly, University of Ibadan (UI) (2020) December 18-23, 2018.
  • [7] Aoi J, Endo M, Kadomatsu T, Miyata K, Ogata A, Horiguchi H, Odagiri H, Masuda T, Fukushima S, Jinnin M, Hirakawa S, Sawa T, Akaike T, Ihn H, Oike Y. Angiopoietin-like protein 2 accelerates carcinogenesis by activating chronic inflammation and oxidative stress. Mol Cancer Res. (2014) 12: 239-249
  • [8] Badru AI, Kanmodi KK, Ogundipe P, Owadokun A, Adesina MA. Opinions of Nigerian religious leaders and seminarians on what causes cancer: A short report. Journal of Alternative Medical Research (2019) 11(2): 165-167
  • [9] Barcellos-Hoff MH, Lyden D, Wang TC. The evolution of the cancer niche during multistage carcinogenesis. Nat Rev Cancer (2013) 13: 511-8
  • [10] Barton D, Loprinzi C. Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible. Clin Breast Cancer (2002) 3, S121-127
  • [11] Bergamo C, Sigel K, Mhango G, Kale M, Wisnivesky JP. Inequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study. Psychosomatic medicine (2014) 76(3): 215-220. doi: 10.1097/PSY.0000000000000050
  • [12] Bortolato B, Hyphantis TN, Valpione S, Perini G, Maes M, Morris G, et al. Depression in cancer: The many biobehavioral pathways driving tumor progression. Cancer Treat. Rev. (2017) 52: 58-70. doi: 10.1016/j.ctrv.2016.11.004
  • [13] Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin (2018) 68: 394-424
  • [14] Brown MS, Simon JH, Stemmer SM, et al. MR and proton spectroscopy of white matter disease induced by high-dose chemotherapy with bone marrow transplant in advanced breast carcinoma. AJNR Am J Neuroradiol (1995) 16:2013-2020
  • [15] Capuron L, Dantzer R: Cytokines and depression: the need for a new paradigm. Brain Behav Immun (2003) 17: 119- 124
  • [16] Capuron L, Ravaud A, Dantzer R: Timing and specificity of the cognitive changes induced by interleukin- 2 and interferon-alpha treatments in cancer patients. Psychosom Med (2001) 63:376-386
  • [17] Chang, CK, Hayes, RD, Broadbent, MT, Hotopf, M, Davies, E, Moller, H, Stewart, R, (2014). A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival. BMJ Open 4 (1), e004295
  • [18] Cunningham, R, Sarfati, D, Stanley, J, Peterson, D, Collings, S. Cancer survival in the context of mental illness: a national cohort study. Gen. Hosp. Psychiatry (2015) 37 (6), 501-506
  • [19] Davis LE, Bogner E, Coburn NG, Hanna TP, Kurdyak P, Groome PA, et al. Stage at diagnosis and survival in patients with cancer and a pre-existing mental illness: a meta-analysis. Journal of Epidemiology and Community Health (2019) jech-2019–212311. https://doi.org/10.1136/jech 2019-212311 PMID: 31653661
  • [20] De Hert M, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S, Correll CU, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011 10(1): 52. https://doi.org/10.1002/j.2051-5545.2011.tb00014.x
  • [21] El-Gabalawy R, Katz LY, Sareen J. Comorbidity and associated severity of borderline personality disorder and physical health conditions in a nationally representative sample. Psychosom Med (2010) 72 :641-647
  • [22] Engholm, GFJ, Christensen, N, AMT, Kejs, Hertzum-Larsen, R, Johannesen, TB, Khan, S, Leinonen, MK, Ólafsdóttir, E, Petersen, T, LKH, Schmidt, Trykker, H, Storm, HH, (2016).
  • [23] Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 127: 2893-2917
  • [24] Ferlay J, Shin HR, Bray F, Forman D, Mathers CD, Parkin D. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer; Year (2010). Available at: http://globocan.iarc.fr. Last accessed 8/17/2010
  • [25] Filley CM: Toxic leukoencephalopathy. Clin Neuropharmacol (1999) 22: 249-260
  • [26] Fujiwara M, Inagaki M, Nakaya N, et al. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan. Psychiatry and Clinical Neurosciences (2017) 71: 813-825
  • [27] Gutiérrez JB and Salsamendi AL. Fundamientos de ciência toxicológica. Diaz de Santos, Madrid, (2001) p. 155–177
  • [28] Hamzat A, Kanmodi KK, Adesina MA. Stimulant, narcotic and hallucinogen use among long distance commercial drivers in Sokoto: A survey on prevalence and consequential knowledge. International Journal of Public Health (2019) 11(2):129-137
  • [29] Howard LM, Barley EA, Davies E, et al. Cancer diagnosis in people with severe mental illness: Practical and ethical issues. The Lancet Oncology (2010) 11: 797-804
  • [30] Hwangbo Y, Kang D, Kang M et al. Incidence of diabetes after cancer development: A Korean national cohort study. JAMA Oncol (2018) 4: 1099-1105
  • [31] James M, Thomas M, Frolov L, et al. Rates of cervical cancer screening among women with severe mental illness in the public health system. Psychiatric Services (2017) 68: 839–842
  • [32] Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin (2011) 61: 69-90
  • [33] Jung KW, Won YJ, Kong HJ et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat (2018) 50: 303-316
  • [34] Kanmodi KK, Nnebedum N, Bello M, Adesina MA, Fagbule OF, Adesoye O. Head and Neck Cancer Awareness: A Survey of young people in international communities. International Journal of Adolescent Medicine and Health (2019) doi:10.1515/ijamh-2018-0231
  • [35] Kisely S, Crowe E and Lawrence D Cancer-related mortality in people with mental illness. JAMA Psychiatry (2013) 70: 209-221
  • [36] Kisely S, Crowe E, Lawrence D. Cancer-related mortality in people with mental illness. JAMA Psychiatry (2013); 70(2): 209. https://doi.org/10.1001/jamapsychiatry
  • [37] Kisely S, Forsyth S, Lawrence D. Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower? Aust N Z J Psychiatry. (2016) 50(3):254–63 Epub 2015/04/02.https://doi.org/10.1177/0004867415577979
  • [38] Kisely S, Sadek J, MacKenzie A, et al. Excess cancer mortality in psychiatric patients. Can J Psychiatry (2008) 53: 753–761
  • [39] Kissane DW, Grabsch B, Love A et al. Psychiatric disorder in women with early stage and advanced breast cancer: A comparative analysis. Aust N Z J Psychiatry 2004 38:320–326
  • [40] Lacour B, Goujon S, Guissou S, Guyot-Goubin A, Desmee S, Desandes E, et al. Childhood cancer survival in France, 2000-2008. Eur J Cancer Prev (2014) 23: 449–57; doi: https:// doi. org/ 10. 1097/ CEJ. 0000000000000006
  • [41] Laursen, TM, Nordentoft, M, Mortensen, PB. Excess earlymortality in schizophrenia. Annu. Rev. Clin. Psychol. (2014) 10, 425–448
  • [42] Lawrence D, Hancock KJ and Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: Retrospective analysis of population based registers. BMJ (2013) 346: f2539
  • [43] Lee J, Lee JS, Park SH et al. Cohort profile: The National Health Insurance Service–National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol (2017) 46:e15
  • [44] Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr. (2017) 30:1–16. doi: 10.1017/neu.2016.69&domain=pdf
  • [45] Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand (2007) 116: 317–333
  • [46] Levinson D, Karger CJ, Haklai Z. Chronic physical conditions and use of health services among persons with mental disorders: results from the Israel National Health Survey. Gen Hosp Psychiatry (2008) 30: 226–232
  • [47] Lin J, McGlynn KA, Carter CA, Nations JA, Anderson WF, Shriver CD, et al. The Impact of Pre Existing Mental Health Disorders on the Diagnosis, Treatment and Survival among Lung Cancer Patients in the U.S. Military Health System. Cancer Epidemiology, Biomarkers and Prevention. (2016); https://doi.org/ 10.1158/1055-9965.EPI-16-0316
  • [48] Liu NH, Daumit GL, Dua T, et al. Excess mortality in persons with severe mental disorders: A multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry (2017) 16: 30–40
  • [49] Loeb LA, Harris CC. Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res. (2008) 68:6863-72
  • [50] Lupien SJ, Gillin CJ, Hauger RL: Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans. Behav Neurosci (1999) 113:420-430
  • [51] Lutgendorf SK, Andersen BL. Biobehavioral approaches to cancer progression and survival: Mechanisms and interventions. Am Psychol (2015) 70:186–197
  • [52] Madhyastha S, Somayaji SN, Rao MS, et al. Hippocampal brain amines in methotrexate-induced learning and memory deficit. Can J Physiol Pharmacol (2002) 80:1076-1084
  • [53] Maier SF, Watkins LR: Immune-to-central nervous system communication and its role in modulating pain and cognition: implications for cancer and cancer treatment. Brain Behav Immun (2003) 17:125-131
  • [54] Manderbacka, K, Arffman, M, Suvisaari, J, Ahlgren-Rimpilainen, A, Lumme, S, Keskimaki, I, Pukkala, E. Effect of stage, comorbidities and treatment on survival among cancer patients with or without mental illness. Br. J. Psychiatry (2017) 211 (5), 304–309
  • [55] Meyers CA: Mood and cognitive disorders in cancer patients receiving cytokine therapy. Adv Exp Med Biol (1999) 461:75-81
  • [56] Mihaela Aldea, Lucian Craciun, Ciprian Tomuleasa, Carmen Crivii. The role of depression and neuroimmune axis in prognosis of cancer patients. JBUON (2014) 19(1): 5-14
  • [57] Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry (2009) 65:732–41; doi: 10.1016/j.biopsych.2008.11.029
  • [58] Mitchell AJ, Chan M, Bhatti H et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of interview-based studies. Lancet Oncol (2011) 12:160–174
  • [59] Myrskyla M, Kohler HP, Billari FC. Advances in development reverse fertility declines. Nature (2009) 460: 741–43
  • [60] Olufadewa II, Adesina MA, Ayorinde T. From Africa to the World: Reimagining Africa’s research capacity and culture in the global knowledge economy. Journal of Global Health (2020) 10(1)
  • [61] Olufadewa II, Adesina MA. “I was scared I might die alone”: A qualitative study on the physiological and psychological experiences of covid-19 survivors and the quality of care received at health facilities. Journal of Travel Medicine and Global Health (2020) 8(2):51-57
  • [62] Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer (2010) 10: 403–14
  • [63] Posner JB: Neurologic Complications of Cancer. Philadelphia: Davis (1995)
  • [64] Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. (2013) 19:1423-37
  • [65] Reeves WC, Strine TW, Pratt LA, et al. Centers for Disease Control and Prevention (CDC). Mental illness surveillance among adults in the United States. MMWR Surveill Summ (2011) 60(Suppl 3): 1–29
  • [66] Reichenberg A, Yirmiya R, Schuld A, et al. Cytokine associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry (2001) 58:445-452
  • [67] Rodin G. Effective treatment for depression in patients with cancer. Lancet (2014) 384: 1076–1078
  • [68] Safdieh JJ, Schwartz D, Rineer J, Weiner JP, Wong A, Schreiber D. Does the Presence of a Major Psychiatric Disorder Affect Tolerance and Outcomes in Men With Prostate Cancer Receiving Radiation Therapy? American journal of men’s health. (2015); Epub 2015/10/22. https://doi.org/10.1177/1557988315610626 PMID: 26487340.
  • [69] Sapienza C, Issa JP. Diet, Nutrition, and Cancer Epigenetics. Annu Rev Nutr. 2016 Jul 17; 36: 665-81. doi: 10.1146/annurev-nutr-121415-112634
  • [70] Siantz E, Wu B, Shiroishi M, et al. Mental illness is not associated with adherence to colorectal cancer screening: Results from the California health interview survey. Digestive Diseases and Sciences (2017) 62: 224–234
  • [71] Sinding C, Watt L, Miller P, Silliker J, Lawson L, Kislinsky C, et al. Stigmas and silos: Social Workers’ accounts of care for people with serious mental illness and cancer. Social Work in Mental Health. (2013) 11: 288–309
  • [72] Sun Y, Vedsted P, Fenger-Gron M, Wu CS, Bech BH, Olsen J, et al. Cancer Mortality in People Treated with Antidepressants before Cancer Diagnosis: A Population Based Cohort Study. PLoS One (2015) 10 (9): e0138134. https://doi.org/10.1371/journal.pone.0138134
  • [73] Tokarz P, Blasiak J. Role of mitochondria in carcinogenesis. Acta Biochim Pol. (2014) 61: 71-8
  • [74] Troy L, McFarland K, Littman-Power S, et al. Cisplatin- based therapy: a neurological and neuropsychological review. Psychooncology (2000) 9: 29-39
  • [75] Varan A, Kebudi R. Secondary malignant neoplasms after childhood cancer. Pediatr Hematol Oncol (2011) 28: 345–53. doi: https://doi.org/10.3109/ 08880018.2011.553879
  • [76] Vigliani MC, Yaya-Tur R, Delattre JY: Combined radiation and chemotherapy-induced disorders of the brain and spinal cord. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. New York, North Holland (1997) pp 353-370
  • [77] Walker J, Hansen CH, Martin P et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: A cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry (2014) 1: 343–350
  • [78] Weinstein LC, Stefancic A, Cunningham AT, Hurley KE, Cabassa LJ, Wender RC. Cancer screening, prevention, and treatment in people with mental illness. CA: a cancer journal for clinicians. (2016) 66 (2): 134–51; Epub 2015/12/15. https://doi.org/10.3322/caac.21334
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-f694e119-47a0-4443-9ac1-078b258c12d0
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.